Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 10/2013

01-10-2013 | Original Article

Changes in frailty-related characteristics of the hip fracture population and their implications for healthcare services: evidence from Quebec, Canada

Authors: M. Auais, S. Morin, L. Nadeau, L. Finch, N. Mayo

Published in: Osteoporosis International | Issue 10/2013

Login to get access

Abstract

Summary

This study provides evidence that a number of frailty-related characteristics (older age, de novo admission to long-term care (LTC), comorbidities [Charlson Index, osteoporosis, osteoporosis risk factors, sarcopenia risk factors, and dementia]) have increased in the hip fracture population from 2001–2008. This will have significant impact on community resources, as the number of people discharged to the community is also increasing.

Introduction

The aim of this study is to estimate secular changes in the prevalence of selected frailty-related characteristics among the hip fracture population in the Canadian province of Quebec (2001–2008) and the potential impact of these changes on healthcare services.

Methods

The Quebec hospitalization database was used to identify nontraumatic hip fractures for the purposes of calculating age- and sex-specific rates. Also estimated were time trends for selected frailty-related characteristics and discharge destinations.

Results

A significant decline in fracture rates was evident for all age groups except for those <65; sex differences were also observed. Almost all frailty-related characteristics increased over time, ranging from 2 to 14 % per year, which translates to an estimated increase from 16 to 112 %, over the study period. For those whose prior living arrangement was LTC, rates of hip fractures declined significantly (women OR = 0.93, 0.91–0.95; men OR = 0.97, 0.94–0.99). In-hospital mortality and discharge to inpatient rehabilitation decreased, while discharges back to community and to LTC increased.

Conclusions

Although hip fracture rates decreased for older hip fracture patients, the absolute number and prevalence of specific frailty-related characteristics increased. Policy makers should review care models to ensure that adequate resources are provided to the community to offset the expected increase in demand arising from ongoing changes in patients’ characteristics.
Appendix
Available only for authorised users
Literature
1.
Cooper C, Campion G, Melton LJ III (1992) Hip fractures in the elderly: a worldwide projection. Osteoporos Int 2:285–289PubMedCrossRef
2.
3.
Papadimitropoulos EA, Coyte PC, Josse RG, Greenwood CE (1997) Current and projected rates of hip fracture in Canada. CMAJ 157:1357–1363PubMed
4.
5.
Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G (2004) Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol Ser A: Biol Sci Med Sci 59:M255–M263CrossRef
6.
Espinoza S, Walston JD (2005) Frailty in older adults: insights and interventions. Cleve Clin J Med 72:1105–1112PubMedCrossRef
7.
Mitnitski A, Graham J, Mogilner A, Rockwood K (2002) Frailty, fitness, and late-life mortality in relation to chronological and biological age. BMC Geriatr 2:1PubMedCrossRef
8.
Shatenstein B (2011) Frailty and cognitive decline: links, mechanisms, and future directions. J Nutr Health & Aging 15:665–666CrossRef
9.
Samper-Ternent R, Snih A, Soham R, Mukaila A, Markides KS, Ottenbacher KJ (2008) Relationship between frailty and cognitive decline in older Mexican Americans. J Am Geriatr Soc 56:1845–1852PubMedCrossRef
10.
Kulminski AM, Ukraintseva SV, Kulminskaya IV, Arbeev KG, Land K, Yashin AI (2008) Cumulative deficits better characterize susceptibility to death in elderly people than phenotypic frailty: lessons from the cardiovascular health study. J Am Geriatr Soc 56:898–903PubMedCrossRef
11.
Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA, Tracy JK, Hochberg MC, Rodondi N, Cawthon PM (2007) Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol Ser A Biol Sci Med Sci 62:744–751CrossRef
12.
Rolland Y, Abellan V, Kan G, Benetos A, Blain H, Bonnefoy M, Chassagne P, Jeandel C, Laroche M, Nourhashemi F, Orcel P, Piette F, Ribot C, Ritz P, Roux C, Taillandier J, Tremollieres F, Weryha G, Vellas B (2008) Frailty, osteoporosis, and hip fracture: causes, consequences, and therapeutic perspectives. J Nutr Health Aging 12:335–346PubMedCrossRef
13.
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383PubMedCrossRef
14.
Levy AR, Mayo NE, Grimard G (1995) Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981–1992. Am J Epidemiol 142:428–436PubMed
15.
Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Cli Epidemiol 45:613–619CrossRef
16.
17.
Mayo NE, Nadeau L, Daskalopoulou SS, Cote R (2007) The evolution of stroke in Quebec: a 15-year perspective. Neurology 68:1122–1127PubMedCrossRef
18.
Leslie WD, O’ Donnell S, Jean S (2009) Trends in hip fracture rates in Canada. JAMA: J Am Med Assoc 302:883–889CrossRef
19.
Wildner M, Clark DE (2001) Hip fracture incidence in east and west Germany: reassessment 10 years after unification. Osteoporos Int 12:136–139PubMedCrossRef
20.
Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori l, Järvinen M (1999) Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 353:802–805PubMedCrossRef
21.
Holt G, Smith R, Duncan K, Hutchison JD, Reid D (2009) Changes in population demographics and the future incidence of hip fracture. Injury 40:722–726PubMedCrossRef
22.
Finsen V, Johnsen LG, Trano G, Hansen B, Sneve KS (2004) Hip fracture incidence in central Norway: a follow-up study. Clin Orthop Relat Res 173–178
23.
Hernandez JL, Olmos JM, Alonso MA, Gonzalez-Fernandez CR, Martinez J, Pajaron M, Llorca J, Gonzalez-Macias J (2006) Trend in hip fracture epidemiology over a 14-year period in a Spanish population. Osteoporos Int 17:464–470PubMedCrossRef
24.
Melton L, Kearns A, Atkinson E, Bolander M, Achenbach S, Huddleston J, Therneau T, Leibson C (2009) Secular trends in hip fracture incidence and recurrence. Osteoporos Int 20:687–694PubMedCrossRef
25.
Fisher AA, O’Brien ED, Davis MW (2009) Trends in hip fracture epidemiology in Australia: possible impact of bisphosphonates and hormone replacement therapy. Bone 45:246–253PubMedCrossRef
26.
Lofman O, Berglund K, Larsson L, Toss G (2002) Changes in hip fracture epidemiology: redistribution between ages, genders, and fracture types. Osteoporos Int 13:18–25PubMedCrossRef
27.
Chevalley T, Guilley E, Herrmann FR, Hoffmeyer P, Rapin CH, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991–2000): reversal of a secular trend. Bone 40:1284–1289PubMedCrossRef
28.
Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L, Adachi JD (2005) Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res 20:898–905PubMedCrossRef
29.
Vanasse A, Orzanco MG, Dagenais P, Ouarda T, Courteau J, Asghari S, Chebana F, Martel B, Gosselin P (2012) Secular trends of hip fractures in Quebec. Can Osteoporos Int 23:1665–1672CrossRef
30.
Zetterberg C, Elmerson S, Andersson GB (1984) Epidemiology of hip fractures in Goteborg, Sweden, 1940–1983. Clin Orthop Relat Res 43–52
31.
Nilsson BE, Obrant KJ (1978) Secular tendencies of the incidence of fracture of the upper end of the femur. Acta Orthop Scand 49:389–391PubMedCrossRef
32.
Haleem S, Lutchman L, Mayahi R, Grice JE, Parker MJ (2008) Mortality following hip fracture: trends and geographical variations over the last 40 years. Injury 39:1157–1163PubMedCrossRef
33.
Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20:1633–1650PubMedCrossRef
34.
Morin S, Lix L, Azimaee M, Metge C, Majumdar S, Leslie W (2011) Institutionalization following incident nontraumatic fractures in community-dwelling men and women. Osteoporosis International 23(9):2381–2386PubMedCrossRef
35.
Bonar SK, Tinetti ME, Speechley M, Cooney LM (1990) Factors associated with short- versus long-term skilled nursing facility placement among community-living hip fracture patients. J Am Geriatr Soc 38:1139–1144PubMed
36.
Melton LJ III (2003) Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 18:1139–1141PubMedCrossRef
37.
Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care, and cost in Canada. Osteoporos Int 12:271–278PubMedCrossRef
38.
Fitzgerald JF, Moore PS, Dittus RS (1988) The care of elderly patients with hip fracture. N Engl J Med 319:1392–1397PubMedCrossRef
39.
Sebestyen A, Boncz I, Toth F, Pentek M, Nyarady J, Sandor J (2008) Correlation between risk factors and mortality in elderly patients with femoral neck fracture with 5-year follow-up. Orv Hetil 149:493–503PubMedCrossRef
40.
Cadarette SM, Katz JN, Brookhart MA, Levin R, Stedman MR, Choudhry NK, Solomon DH (2008) Trends in drug prescribing for osteoporosis after hip fracture, 1995–2004. J Rheumatol 35:319–326PubMed
41.
Salgueiro ME, Manso G, Castells X, Jimeno FJ, Ordonez L, Gonzalez V, Rodriguez A, Capella D (2013) Trends in the pharmacological treatment of osteoporosis in Spain from 2000 to 2008. Maturitas 74:74–78PubMedCrossRef
42.
Stafford RS, Drieling RL, Hersh AL (2004) National trends in osteoporosis visits and osteoporosis treatment, 1988–2003. Arch Intern Med 164:1525–1530PubMedCrossRef
43.
Friedman SM, Menzies IB, Bukata SV, Mendelson DA, Kates SL (2010) Dementia and hip fractures. Geriatr Orthop Surg Rehabil 1:52–62PubMedCrossRef
44.
Bertram M, Norman R, Kemp L, Vos T (2011) Review of the long-term disability associated with hip fractures. Inj Prev 17:365–370PubMedCrossRef
45.
46.
El Maghraoui A, Ngbanda A, Bensaoud N, Bensaoud M, Rezqi A, Tazi M (2013) Age-adjusted incidence rates of hip fractures between 2006 and 2009 in Rabat, Morocco. Osteoporos Int 24:1267–1273PubMedCrossRef
47.
Boufous S, Finch CF, Lord SR (2004) Incidence of hip fracture in New South Wales: are our efforts having an effect? Med J Aust 180:623–626PubMed
48.
Gehlbach SH, Avrunin JS, Puleo E (2007) Trends in hospital care for hip fractures. Osteoporos Int 18:585–591PubMedCrossRef
49.
Marks R (2010) Hip fracture epidemiological trends, outcomes, and risk factors, 1970–2009. Int J Gen Med 3:1–17PubMed
50.
Mazzaferro S, Pasquali M, Pirro G, Rotondi S, Tartaglione L (2010) The bone and the kidney. Arch Biochem Biophys 503:95–102PubMedCrossRef
51.
Buford TW, Anton SD, Judge AR, Marzetti E, Wohlgemuth SE, Carter CS, Leeuwenburgh C, Pahor M, Manini TM (2010) Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev 9:369–383PubMedCrossRef
52.
Unnanuntana A, Rebolledo BJ, Khair MM, DiCarlo EF, Lane JM (2011) Diseases affecting bone quality: beyond osteoporosis. Clin Orthop Relat Res 469:2194–2206PubMedCrossRef
53.
Balzarini L, Mancini C, Mouzakiti P, Confortini M, Marvisi M (2011) Osteoporosis associated with chronic obstructive pulmonary disease and other respiratory diseases. Recenti Prog Med 102:359–366PubMed
54.
Boling EP (2004) Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis. Clin Ther 26:1–14PubMedCrossRef
55.
Embutnieks IUV, Drozdov VN, Chernyshova IV, Topcheeva ON, Koricheva ES, Albulova EA (2011) Disorder of bone mineral density in patients with the digestive system diseases. Eksp Klin Gastroenterol 111–116
56.
Southerland JC, Valentine JF (2001) Osteopenia and osteoporosis in gastrointestinal diseases: diagnosis and treatment. Curr Gastroenterol Rep 3:399–407PubMedCrossRef
57.
Varenna M, Manara M, Cantatore FP, Del PA, Di MO, Malavolta N, Minisola G, Adami S, Sinigaglia L, Rossini M (2012) Determinants and effects of vitamin D supplementation on serum 25-Hydroxy-vitamin D levels in patients with rheumatoid arthritis. Clin Exp Rheumatol 30:714–719PubMed
58.
Gonzalez-Reimers E, Alvisa-Negrin J, Santolaria-Fernandez F, Ros-Vilamajo R, Martin-Gonzalez MC, Hernandez-Betancor I, Garcia-Valdecasas-Campelo E, Gonzalez-Diaz A (2011) Prognosis of osteopenia in chronic alcoholics. Alcohol 45:227–238PubMedCrossRef
59.
Mazzuoli GF, D’Erasmo E, Pisani D (1998) Primary hyperparathyroidism and osteoporosis. Aging (Milano) 10:225–231
Metadata
Title
Changes in frailty-related characteristics of the hip fracture population and their implications for healthcare services: evidence from Quebec, Canada
Authors
M. Auais
S. Morin
L. Nadeau
L. Finch
N. Mayo
Publication date
01-10-2013
Publisher
Springer London
Published in
Osteoporosis International / Issue 10/2013
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-013-2390-x

Other articles of this Issue 10/2013

Osteoporosis International 10/2013 Go to the issue

Original Article

The risk of falls on initiation of antihypertensive drugs in the elderly

Original Article

An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX®

Original Article

Replication of Caucasian loci associated with bone mineral density in Koreans

Original Article

Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs—an analysis using national health databases

Short Communication

The impact of decreasing U.S. hip fracture rates on future hip fracture estimates

Original Article

Failure after osteosynthesis of trochanteric fractures. Where is the limit of osteoporosis?